新型冠状病毒肺炎与风湿病学：真的有必要进行防护吗？
COVID-19 and rheumatology: is shielding really necessary?
作者信息
Amani Lisa, Warraich Rabia, Patel Nishil, Tahir Hasan
机构信息
Department of General Medicine, Barnet Hospital, Royal Free London NHS Foundation Trust, London, UK.
Department of Clinical Haematology, Barnet Hospital, Royal Free London NHS Foundation Trust, London, UK.
出版信息
Br J Hosp Med (Lond). 2020 Jun 2;81(6):1-3. doi: 10.12968/hmed.2020.0284. Epub 2020 Jun 3.
Rheumatology patients who are taking immunosuppressants are considered to be at 'high risk' from COVID-19, hence have been self-isolating or shielding. However, they may be protected from the features of hyperinflammation driven by a 'cytokine storm', so may have better clinical outcomes if infected. This editorial discusses whether it may not be necessary to advise these patients to shield.
正在服用免疫抑制剂的风湿病患者被认为面临感染新冠病毒的“高风险”，因此一直在自我隔离或进行防护。然而，他们可能会免受“细胞因子风暴”引发的过度炎症影响，所以如果感染，可能会有更好的临床结果。这篇社论讨论了是否没有必要建议这些患者进行防护。
Zotero 插件